Actinium Pharmaceuticals, Inc. 10-Q filing
Filed 2025-11-14 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001213900-25-110979
- Form type
- 10-Q
- CIK
- 0001388320
- Primary document
- https://www.sec.gov/Archives/edgar/data/1388320/000121390025110979/ea0262047-10q_actinium.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Actinium Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $90,000 | - | - |
| Operating Income | $-29.8M | - | - |
| Net Income | $-27.9M | - | - |
| Eps Basic | -0.9 | - | - |
| Eps Diluted | -0.9 | - | - |
| Cash And Equivalents | $53.4M | - | - |
| Total Assets | $56.2M | - | - |
| Total Liabilities | $42.4M | - | - |
| Shareholders Equity | $13.8M | - | - |
| Operating Cash Flow | $-19.3M | - | - |
| Capital Expenditures | $11,000 | - | - |